State-Level Marketing Restrictions Increasingly Target Device Industry
This article was originally published in The Gray Sheet
As more states try to exert control over marketing by pharmaceutical manufacturers, it appears increasingly likely that device companies will become swept up in the tide
You may also be interested in...
Budget shortfalls in state governments throughout the country increase the importance of strong industry coalitions at that level to lobby on behalf of medical technology, industry representatives say
Orthopedic device manufacturers are out ahead of the drug industry in adapting to new payment disclosure laws. One company, Stryker, has embraced the requirement wholeheartedly and may have found a way to make the listing a benefit to doctors and patients.
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.